Department of Radiation Oncology, Washington University School of Medicine, 4511 Forest Park Boulevard, St. Louis, Missouri 63108, USA.
Nucleic Acids Res. 2012 Jan;40(2):726-38. doi: 10.1093/nar/gkr748. Epub 2011 Sep 27.
Homologous recombination (HR) is a major mechanism utilized to repair blockage of DNA replication forks. Here, we report that a sister chromatid exchange (SCE) generated by crossover-associated HR efficiently occurs in response to replication fork stalling before any measurable DNA double-strand breaks (DSBs). Interestingly, SCE produced by replication fork collapse following DNA DSBs creation is specifically suppressed by ATR, a central regulator of the replication checkpoint. BRCA1 depletion leads to decreased RPA2 phosphorylation (RPA2-P) following replication fork stalling but has no obvious effect on RPA2-P following replication fork collapse. Importantly, we found that BRCA1 promotes RAD51 recruitment and SCE induced by replication fork stalling independent of ATR. In contrast, BRCA1 depletion leads to a more profound defect in RAD51 recruitment and SCE induced by replication fork collapse when ATR is depleted. We concluded that BRCA1 plays a dual role in two distinct HR-mediated repair upon replication fork stalling and collapse. Our data established a molecular basis for the observation that defective BRCA1 leads to a high sensitivity to agents that cause replication blocks without being associated with DSBs, and also implicate a novel mechanism by which loss of cell cycle checkpoints promotes BRCA1-associated tumorigenesis via enhancing HR defect resulting from BRCA1 deficiency.
同源重组(HR)是修复 DNA 复制叉阻塞的主要机制。在这里,我们报告说,在任何可测量的 DNA 双链断裂(DSB)发生之前,由交叉相关 HR 产生的姐妹染色单体交换(SCE)可以有效地响应复制叉停滞。有趣的是,在创建 DNA DSB 后,由复制叉崩溃产生的 SCE 被复制检查点的中央调节剂 ATR 特异性抑制。BRCA1 耗竭会导致复制叉停滞后 RPA2 磷酸化(RPA2-P)减少,但对复制叉崩溃后 RPA2-P 没有明显影响。重要的是,我们发现 BRCA1 可促进 RAD51 的募集,并独立于 ATR 促进由复制叉停滞引起的 SCE。相比之下,当 ATR 耗尽时,BRCA1 耗竭会导致复制叉崩溃时 RAD51 募集和 SCE 诱导的缺陷更为严重。我们得出结论,BRCA1 在复制叉停滞和崩溃时的两种不同 HR 介导的修复中发挥双重作用。我们的数据为以下观察结果提供了分子基础:有缺陷的 BRCA1 导致对引起复制阻滞而不与 DSB 相关的试剂高度敏感,并且还暗示了一种新的机制,即细胞周期检查点的丧失通过增强由 BRCA1 缺陷引起的 HR 缺陷来促进 BRCA1 相关的肿瘤发生。